#oncology
New pancreatic cancer drug shows major survival gains in Phase 3 study
REDWOOD CITY, California — Revolution Medicines announced positive results from a late-stage clinical trial evaluating its experimental drug daraxonrasib, showing a significant survival benefit for patients with advanced pancreatic cancer who had previously undergone treatment. According to the company, patients receiving the once-daily oral therapy lived a median of 13.2 months, compar
New pancreatic cancer drug shows major survival gains in Phase 3 study
REDWOOD CITY, California — Revolution Medicines announced positive results from a late-stage clinical trial evaluating its experimental drug daraxonrasib, showing a significant survival benefit for patients with advanced pancreatic cancer who had previously undergone treatment. According to the company, patients receiving the once-daily oral therapy lived a median of 13.2 months, compar
ISDE India Edition 2026 Conference with Nandamuri Balakrishna Highlights Esophageal Cancer Research
The ISDE India Edition 2026, a two-day international conference on esophageal cancer, was inaugurated on April 10, 2026, by Shri Nandamuri Balakrishna, Chairman & Managing Trustee of NBTRMCF, at The Westin Hyderabad, Madhapur. This is the first time the conference is being held in India, emphasizing the country’s growing role in esophageal cancer research and clinical expertise. The conference, in association with the Basavatarakam Indo-American Cancer Hospital & Research Institute
ISDE India Edition 2026 Conference with Nandamuri Balakrishna Highlights Esophageal Cancer Research
The ISDE India Edition 2026, a two-day international conference on esophageal cancer, was inaugurated on April 10, 2026, by Shri Nandamuri Balakrishna, Chairman & Managing Trustee of NBTRMCF, at The Westin Hyderabad, Madhapur. This is the first time the conference is being held in India, emphasizing the country’s growing role in esophageal cancer research and clinical expertise. The conference, in association with the Basavatarakam Indo-American Cancer Hospital & Research Institute
Immunotherapy Breakthrough Gives New Hope for Colorectal Cancer Patients
Colorectal cancer is currently the third most common cancer in the world, following lung and breast cancers. In recent years, doctors and researchers have noticed a steady increase in cases across many countries, including India. Despite the rising number of diagnoses, new medical advancements are offering hope to patients. One of the most promising developments is immunotherapy, a treatment that helps the body’s immune system detect and attack cancer cells more effectively. Unlik
Immunotherapy Breakthrough Gives New Hope for Colorectal Cancer Patients
Colorectal cancer is currently the third most common cancer in the world, following lung and breast cancers. In recent years, doctors and researchers have noticed a steady increase in cases across many countries, including India. Despite the rising number of diagnoses, new medical advancements are offering hope to patients. One of the most promising developments is immunotherapy, a treatment that helps the body’s immune system detect and attack cancer cells more effectively. Unlik
Biden begins new radiation and hormone therapy for prostate cancer
Former US president Joe Biden has embarked upon a new stage in his medical care after a diagnosis of aggressive prostate cancer earlier this year, his spokesperson confirmed on Saturday. The spokesman said that, in conjunction with an existing hormone regimen, Biden is now receiving a course of radiation therapy as part of a broader treatment plan for his prostate cancer. According to the spokesperson, the radiation phase is scheduled to continue for five weeks, marking a significan
Biden begins new radiation and hormone therapy for prostate cancer
Former US president Joe Biden has embarked upon a new stage in his medical care after a diagnosis of aggressive prostate cancer earlier this year, his spokesperson confirmed on Saturday. The spokesman said that, in conjunction with an existing hormone regimen, Biden is now receiving a course of radiation therapy as part of a broader treatment plan for his prostate cancer. According to the spokesperson, the radiation phase is scheduled to continue for five weeks, marking a significan
Russia’s Enteromix Cancer Vaccine Shows 100% Efficacy In Early Trials
Russia has taken a major step in the global fight against cancer with the announcement of Enteromix, a new mRNA-based cancer vaccine that has shown 100% efficacy and safety in early human trials. Developed by the National Medical Research Radiological Centre and the Engelhardt Institute of Molecular Biology, Enteromix was tested on 48 patients with colorectal cancer. The results revealed tumour shrinkage and zero serious side effects, positioning this innovatio
Russia’s Enteromix Cancer Vaccine Shows 100% Efficacy In Early Trials
Russia has taken a major step in the global fight against cancer with the announcement of Enteromix, a new mRNA-based cancer vaccine that has shown 100% efficacy and safety in early human trials. Developed by the National Medical Research Radiological Centre and the Engelhardt Institute of Molecular Biology, Enteromix was tested on 48 patients with colorectal cancer. The results revealed tumour shrinkage and zero serious side effects, positioning this innovatio









